Aligned Genetics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	16,016	15,778	15,215	13,753	11,762
Other Revenue	-0	-	-0	-0	-
Revenue	16,016	15,778	15,215	13,753	11,762
Revenue Growth (YoY)	1.51%	3.70%	10.63%	16.92%	47.82%
Cost of Revenue	4,794	4,629	4,556	4,998	4,424
Gross Profit	11,221	11,148	10,659	8,755	7,338
Selling, General & Admin	6,240	5,619	5,125	4,287	3,791
Research & Development	2,017	2,292	1,684	1,079	943.58
Amortization of Goodwill & Intangibles	29.13	15.7	19.3	21.33	35.46
Other Operating Expenses	105.01	96.87	84.21	77.31	59.34
Operating Expenses	8,779	8,369	7,322	5,906	5,159
Operating Income	2,443	2,780	3,337	2,849	2,179
Interest Expense	-103.88	-169.15	-214.88	-165.96	-28.88
Interest & Investment Income	328.93	405.32	161.61	168.16	27.71
Currency Exchange Gain (Loss)	85.02	1,530	302.06	17.89	353.05
Other Non Operating Income (Expenses)	34.63	33.59	8.09	83.88	-238.9
EBT Excluding Unusual Items	2,788	4,579	3,594	2,953	2,292
Gain (Loss) on Sale of Investments	-178.26	-36.7	-147.75	-510.71	1,507
Gain (Loss) on Sale of Assets	10.78	-	-22.04	-	13.94
Other Unusual Items	29.52	-	-	-	-
Pretax Income	2,650	4,542	3,424	2,442	3,813
Income Tax Expense	-261.79	414.26	188.16	109.5	-1,729
Net Income	2,911	4,128	3,236	2,333	5,542
Net Income to Common	2,911	4,128	3,236	2,333	5,542
Net Income Growth	-29.47%	27.57%	38.72%	-57.90%	1083.53%
Shares Outstanding (Basic)	14	14	14	14	14
Shares Outstanding (Diluted)	14	14	14	14	14
Shares Change (YoY)	-1.74%	0.03%	-	-	38.26%
EPS (Basic)	206.00	287.00	225.05	162.23	385.40
EPS (Diluted)	206.00	287.00	225.00	162.00	385.40
EPS Growth	-28.22%	27.56%	38.89%	-57.97%	756.45%
Free Cash Flow	-7,459	2,808	1,970	220.98	-3,171
Free Cash Flow Per Share	-527.80	195.20	137.01	15.37	-220.57
Gross Margin	70.06%	70.66%	70.06%	63.66%	62.38%
Operating Margin	15.25%	17.62%	21.93%	20.72%	18.52%
Profit Margin	18.18%	26.16%	21.27%	16.96%	47.12%
Free Cash Flow Margin	-46.58%	17.79%	12.95%	1.61%	-26.96%
EBITDA	3,052	3,355	3,968	3,499	2,718
EBITDA Margin	19.05%	21.27%	26.08%	25.45%	23.10%
D&A For EBITDA	608.95	575.74	631.38	650.38	538.59
EBIT	2,443	2,780	3,337	2,849	2,179
EBIT Margin	15.25%	17.62%	21.93%	20.72%	18.52%
Effective Tax Rate	-	9.12%	5.50%	4.48%	-
Advertising Expenses	562.03	359.22	261.67	243.86	96.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.